Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,942 total articles
Ming Shing Group Holdings Limited (NASDAQ: PMA), a Hong Kong-based wet trades and graphene technology company, has entered into a stock purchase agreement to acquire Meals Through Seasons Limited for $510 million payable entirely in company securities. The deal involves issuing 150 million Class A ordinary shares and $360 million in unsecured conve…
LPL Financial announced the integration of Conte Wealth Advisors, LLC, a family-led firm managing approximately $1.6 billion in assets, into its broker-dealer and Registered Investment Advisor platforms. This move aims to support CWA's growth by leveraging LPL's technology, resources, and scale to attract and empower advisors while enhancing the cl…
SciSparc Ltd.'s subsidiary NeuroThera Labs, in collaboration with Clearmind Medicine, has advanced their psychedelic drug pipeline with a newly published U.S. patent application covering a novel combination of MDMA and N-acylethanolamines (such as PEA) for the treatment of PTSD, anxiety, and eating disorders. This patent publication coincides with …
Callan JMB Inc. has appointed Michael Reger, founder and former CEO of Northern Oil and Gas, as President of its new subsidiary Callan Power LLC, focused on oil and gas resource development, energy resilience, and domestic manufacturing of critical electrical equipment. Leveraging Reger's extensive energy industry and public company leadership expe…
QCR Holdings, Inc. announced an increase in its quarterly cash dividend to $0.15 per share from $0.10, payable October 5, 2026. This is the second dividend increase in 2026 and highlights the company's strong balance sheet, consistent earnings, and commitment to long-term shareholder value. QCR Holdings operates multiple banks serving communities i…
Rocky Mountain Chocolate Factory, Inc. (Nasdaq: RMCF) announced the appointment of David Denker as Chief Operating Officer. Denker, formerly Vice President of Franchise Development, will oversee manufacturing, franchise operations, and development with a focus on improving production efficiency, aligning cross-functional operations, and advancing o…
Eva Live Inc. announces its 60% majority ownership of International Gaming Alliance (IGA), marking its strategic expansion into the global online gaming and lottery market. IGA has signed a three-year Master Services Agreement with Lottery.com International, enabling operations across multiple international territories. Eva Live will leverage its A…
Expion Energy, Inc. announced the closing of a $9 million initial tranche of a private placement offering involving 8% Convertible Debentures and Warrants, with potential to raise an additional $91 million. The proceeds will be used to acquire oil and gas assets in Eastern Louisiana and for general corporate expenses. The company is broadening its …
CVRx, Inc. announced that Devoted Health, a major Medicare Advantage insurer, has established a coverage policy for its Barostim therapy, effective July 2026. This policy complements existing coverage from Humana and CMS approvals, covering a significant portion of Medicare Advantage members and supporting broader patient access to this FDA-approve…
Aureus Greenway Holdings Inc. (Nasdaq: PUSA) and Powerus have announced the start of manufacturing Guardian counter-UAS interceptors in the Gulf Cooperation Council region through a partnership with a local defense manufacturer. This regional manufacturing is designed to speed delivery of U.S.-designed defense systems to allies facing drone threats…
La Rosa Holdings Corp., a US-based real estate and PropTech company, announced first half 2026 financial results marked by a nearly 10% increase in gross profit to $3.7 million and a 42% reduction in operating loss to $4.2 million compared to the prior year. The company also reported a 25% decrease in operating expenses and a 9.4% improvement in ne…
Lexicon Pharmaceuticals has earned its third $10 million milestone payment in 2026 from Novo Nordisk following successful patient dosing in the Phase 1 trial of LX9851, a novel oral small molecule for obesity and metabolic disorders. This achievement brings total milestone payments to $75 million out of a potential $1 billion collaboration deal. Th…
BioCardia, a leader in cellular therapeutics for cardiovascular diseases, announced FDA confirmation of Pre-Submission Meeting minutes for its Helix Transendocardial Delivery Catheter. This ratification supports BioCardia's planned follow-on pre-submission intended to enable Helix's approval via the De Novo regulatory pathway, potentially accelerat…
Our Bond, Inc., a New York-based international company specializing in AI-powered Preventative Personal Security, announced a live investor webinar hosted by CEO Doron Kempel to discuss recent developments and the company's accelerating momentum. The company operates globally, serving more than 1.25 million security service requests with presence i…
Expion Energy, Inc. (Nasdaq: XPON) announced the acquisition of oil and gas exploration assets in Eastern Louisiana, marking its entry into the oil and gas sector as part of an expanded operating strategy. The company appointed Kevin Sellers as new CEO to lead this platform expansion, and rebranded from Expion360 Inc. to better align with its broad…
Alpha Modus Holdings, Inc. (NASDAQ: AMOD) announced a strategic consulting and business development agreement with Circle The Wagons, Inc. to accelerate deployment of its AI-powered retail platform ARIA and financial service Alpha Cash in the fragmented US independent grocery market, valued at $353 billion. The collaboration aims to rapidly move fr…
Amarin Corporation plc announced upcoming presentations at the European Society of Cardiology (ESC) Congress 2026 featuring new analyses from the REDUCE-IT trial and mechanistic EPA data. These presentations cover treatment adherence, long-term outcomes, and biomarker insights related to cardiovascular risk reduction with icosapent ethyl (VASCEPA/V…
Edible Garden AG, a Nasdaq-listed leader in controlled environment agriculture, announced a strategic partnership with Square Roots to develop a new generation of clean-label, functional ready-to-drink beverages. Combining Square Roots' expertise in plant science with Edible Garden's advanced Farm-to-Formula® platform and aseptic manufacturing, the…
Biogen and Eisai announced US availability of LEQEMBI IQLIK®, a subcutaneous autoinjector for initiation and maintenance therapy of early Alzheimer's disease, offering a more convenient and flexible alternative to intravenous infusion. The treatment, supported by robust clinical trial data demonstrating slowed disease progression and significant co…
Clearmind Medicine Inc., a clinical-stage biotech focused on psychedelic-derived neuroplastogens, announced the U.S. publication of a patent application covering a novel combination of MDMA and N-acylethanolamines such as PEA, aimed at treating PTSD, anxiety, and eating disorders. This comes alongside the FDA's newly finalized guidance for clinical…
Rhythm Pharmaceuticals announced that Japan's Ministry of Health, Labour and Welfare has approved IMCIVREE® (setmelanotide) to treat patients with acquired hypothalamic obesity (HO), a rare disease characterized by significant weight gain due to hypothalamic injury. Supported by positive Phase 3 trial data, this marks IMCIVREE as the first approved…
Evolution Metals & Technologies Corp. (Nasdaq: EMAT), a U.S.-based critical materials and manufacturing company, announced its preliminary inclusion in FTSE Russell's Russell 3000® and Russell 2000® indexes, effective September 21, 2026, pending final review. This inclusion is anticipated to increase the company's visibility among institutional and…
ASML Holding N.V., a global leader in semiconductor equipment manufacturing, has disclosed recent transactions under its ongoing share buyback program announced in January 2026. Over five consecutive days in August, ASML repurchased a total of approximately 252,684 shares at weighted average prices ranging from €1,506.98 to €1,618.13 per share. The…
Elicio Therapeutics announced its management will participate in one-on-one meetings at the Wells Fargo 21st Annual Healthcare Conference to discuss its development of next-generation immunotherapies for KRAS-driven cancers. The company focuses on off-the-shelf immunotherapy candidates, aiming to improve treatment for solid tumors driven by KRAS, B…
Humacyte, Inc. announced that following favorable discussions with the FDA, it intends to file a supplemental Biologics License Application (BLA) in November 2026 to expand approval of its acellular tissue engineered vessel (ATEV) for dialysis access. This follows FDA approval of ATEV for vascular trauma in 2024. The application will be supported b…
